Citation Impact
Citing Papers
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Association of hepatitis C virus envelope proteins with exosomes
2004 StandoutNobel
Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count
2006
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
C‐Reactive Protein (CRP)‐Lowering Agents
2006
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
Cardiovascular manifestations of phaeochromocytoma
2011
Cardiorenal Syndrome
2008 Standout
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
2011 StandoutNobel
Perspectives for a vaccine against hepatitis C virus
1999 StandoutNobel
The long and winding road leading to the identification of the hepatitis C virus
2009 StandoutNobel
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection
2007
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
2008 StandoutNobel
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications
2013
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells
2005 StandoutNobel
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
2010 StandoutNobel
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
2010 StandoutNobel
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
Cancer-related inflammation and treatment effectiveness
2014 Standout
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV
1995 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Long-Term Persistence of Infection in Chimpanzees Inoculated with an Infectious Hepatitis C Virus Clone Is Associated with a Decrease in the Viral Amino Acid Substitution Rate and Low Levels of Heterogeneity
2004 StandoutNobel
Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B‐endemic area
1993
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
The ALIAS Pilot Trial
2006
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
1994 StandoutNobel
Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
1993 StandoutNobel
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy
2014
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge
2002 StandoutNobel
Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin
1996 StandoutNobel
Vaccination of chimpanzees against infection by thehepatitis C virus.
1994
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
The ALIAS Pilot Trial
2006
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses
2006 StandoutNobel
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
The Metabolic Syndrome
2008 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Folding of Hepatitis C Virus E1 Glycoprotein in a Cell-Free System
2001 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Hyun Sook being referenced
Adequately Washed Bronchoscope Does Not Induce False-Positive Amplification Tests on Bronchial Aspirates in the Diagnosis of Pulmonary Tuberculosis
2002
Effects of Celecoxib on High‐Sensitivity C‐Reactive Protein in Chronic Peritoneal Dialysis Patients
2004
High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies
2010
Effect of increasing serum albumin on plasma D-dimer, von Willebrand factor, and platelet aggregation in CAPD patients
1999
Prevalence of Hepatitis C Virus Antibody Among Korean Adults
1992
Systemic Inflammatory Syndrome and Hepatic Inflammatory Cell Infiltration Caused by an Interleukin-6 Producing Pheochromocytoma
2005